Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M-Reference-Cited by-同舟云学术

Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M

Published:2023-01-28 Issue:3 Volume:37 Page:717-719
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Gurnari Carmelo^ORCID,Gagelmann Nico,Badbaran Anita,Awada Hussein,Dima Danai^ORCID,Pagliuca Simona^ORCID,D’Aveni-Piney Maud,Attardi Enrico,Voso Maria Teresa^ORCID,Cerretti Raffaella^ORCID,Wolschke Christine,Rubio Marie Thérèse,Maciejewski Jaroslaw P.^ORCID,Kröger Nicolaus

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-023-01820-4.pdf

Reference15 articles.

1. Lindsley RC, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, et al. Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation. N Engl J Med. 2017;376:536–47.

2. Yoshizato T, Nannya Y, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, et al. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. Blood. 2017;129:2347–58.

3. Fenaux P, Haase D, Santini V, Sanz GF, Platzbecker U, Mey U. Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(†☆). Ann Oncol. 2021;32:142–56.

4. Della Porta MG, Gallì A, Bacigalupo A, Zibellini S, Bernardi M, Rizzo E, et al. Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation. J Clin Oncol. 2016;34:3627–37.

5. Shaffer BC, Ahn KW, Hu ZH, Nishihori T, Malone AK, Valcárcel D, et al. Scoring system prognostic of outcome in patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome. J Clin Oncol. 2016;34:1864–71.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes;Journal of Clinical Oncology;2024-08-20

2. Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?;Blood;2024-07-25

3. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

4. Hematopoietic cell transplantation (HCT) in MDS patients of older age;Leukemia & Lymphoma;2024-02-05

5. Myelodysplastic Neoplasms/Syndromes (MDS);The EBMT Handbook;2024